Investors Research Corp’s Edwards Lifesciences EW Stock Holding History

Investors Research Corp’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$81.2K	Buy	898 +804	+855%	+$67.4K	0.01%	349
2026 Q1	$7.53K	Hold	94	–	–	﹤0.01%	564
2025 Q4	$8.01K	Hold	94	–	–	﹤0.01%	641
2025 Q3	$7.31K	Hold	94	–	–	﹤0.01%	674
2025 Q2	$7.35K	Hold	94	–	–	﹤0.01%	699
2025 Q1	$6.81K	Hold	94	–	–	﹤0.01%	722
2024 Q4	$6.96K	Hold	94	–	–	﹤0.01%	707
2024 Q3	$6.2K	Hold	94	–	–	﹤0.01%	748
2024 Q2	$8.68K	Hold	94	–	–	﹤0.01%	730
2024 Q1	$8.98K	Hold	94	–	–	﹤0.01%	731
2023 Q4	$7.17K	Hold	94	–	–	﹤0.01%	780
2023 Q3	$6.51K	Hold	94	–	–	﹤0.01%	806
2023 Q2	$8.87K	Hold	94	–	–	﹤0.01%	773
2023 Q1	$7.78K	Hold	94	–	–	﹤0.01%	810
2022 Q4	$7.01K	Hold	94	–	–	﹤0.01%	826
2022 Q3	$8K	Buy	94 +29	+45%	+$2.79K	﹤0.01%	777
2022 Q2	$6K	Buy	65 +31	+91%	+$3.21K	﹤0.01%	813
2022 Q1	$4K	Buy	+34	New	+$3.81K	﹤0.01%	858
2021 Q3	–	Sell	-153	Closed	-$16K	–	1005
2021 Q2	$16K	Hold	153	–	–	0.01%	706
2021 Q1	$13K	Hold	153	–	–	﹤0.01%	739
2020 Q4	$14K	Hold	153	–	–	0.01%	796
2020 Q3	$12K	Hold	153	–	–	0.01%	787
2020 Q2	$11K	Hold	153	–	–	0.01%	786
2020 Q1	$10K	Hold	153	–	–	0.01%	774
2019 Q4	$12K	Hold	153	–	–	0.01%	806
2019 Q3	$11K	Buy	+153	New	+$10.7K	0.01%	828

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Investors Research Corp's EW Position: Q2 2026 in Review

Investors Research Corp increased its Edwards Lifesciences (EW) stake by 855% in Q2 2026, buying an estimated $67.4K and bringing the position to 898 shares worth $81.2K. The position accounts for 0.01% of the portfolio, ranked #349.

Investors Research Corp first reported a position in EW in Q3 2019 and has held it in 26 quarters since. 1,328 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Investors Research Corp held 898 shares of Edwards Lifesciences worth $81.2K as of Q2 2026.
Investors Research Corp bought 804 Edwards Lifesciences shares in Q2 2026, an estimated $67.4K.
Edwards Lifesciences made up 0.01% of Investors Research Corp's portfolio in Q2 2026, its #349 holding.
Investors Research Corp first reported a position in Edwards Lifesciences in Q3 2019 and has held it in 26 quarters since.
1,328 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Investors Research Corp's 13F filing for Q2 2026, filed 10 Jul 2026.